Acompanhamento farmacoterapêutico de pacientes pediátricos submetidos à sedoanalgesia em um hospital de alta complexidade em Belém-Pa

Abstract

Introduction: The Intensive Care Unit (ICU) is a hospitalization unit for critically ill patients, whomostly use sedatives and analgesics. Seeking tominimize undesirable events, clinical follow-up of patients, especially pediatric patients, is necessary. Objective: To propose an instrument for pharmacotherapeutic monitoring of patients undergoing sedoanalgesia in the pediatric ICU. Method: Retrospective study, with data collected from medical records of patients aged 0 to 14 years, admitted to the pediatric ICU during the study period, who used sedoanalgesics. Results and discussion: In 326 prescriptions in the 90-day period involving 96 children, the age group of07-09 years predominated, with 49.2% underweight and predominantly male. Among the drugs prescribed were antimicrobials, sedoanalgesics, antipyretics and proton pump inhibitors. The average length of hospital stay was 18.5 days and approximately 32.7% of the patients had Withdrawal Syndrome (AS), corroborating the literature, where it is postulated that the longer thetime of use of these drugs, the greater the risk of SA. In 25% of the patients, 42.5% used antidotesother than those recommended by the Pediatrics and Pediatric & Neonatal Dosage Handbook. Asa product, a Manual for the Use of Sedoanalgesics was prepared to guide the multidisciplinary team in the care of patients during therapy. Conclusion: The data from this research indicated anunderweight public, the occurrence of medication errors and withdrawal syndrome, among otherfactors that reinforce the need for the elaboration of an institutionalized protocol for the administration of sedoanalgesics, aiming to guarantee patient safety, prevent the occurrence of adverse events related to its use and direct the multidisciplinary team on the care to be adopted.